Michalski JM - Search Results

1

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.

Khairnar R, DeMora L, Sandler HM, Lee WR, Villalonga-Olives E, Mullins CD, Palumbo FB, Bruner DW, Shaya FT, Bentzen SM, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Albert M, Currey AD, Pisansky TM, Chen Y, Horwitz EM, DeNittis AS, Feng F, Mishra MV. Khairnar R, et al. Among authors: michalski jm. JCO Clin Cancer Inform. 2022 Jun;6:e2100188. doi: 10.1200/CCI.21.00188. JCO Clin Cancer Inform. 2022. PMID: 35776901 Free PMC article. Clinical Trial.

2

Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors.

Yan D, Wong J, Vicini F, Michalski J, Pan C, Frazier A, Horwitz E, Martinez A. Yan D, et al. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):197-206. doi: 10.1016/s0360-3016(97)00229-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9212024

3

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402. doi: 10.1016/s0360-3016(99)00443-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10661346 Clinical Trial.

4

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.

Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Michalski JM, et al. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):75-80. doi: 10.1053/srao.2002.31378. Semin Radiat Oncol. 2002. PMID: 11917289 Clinical Trial.

5

Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.

Lee WR, Roach M 3rd, Michalski J, Moran B, Beyer D. Lee WR, et al. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):457-61. doi: 10.1016/s0360-3016(02)02950-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12243822

6

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

Ryu JK, Winter K, Michalski JM, Purdy JA, Markoe AM, Earle JD, Perez CA, Roach M 3rd, Sandler HM, Pollack A, Cox JD. Ryu JK, et al. Among authors: michalski jm. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1036-46. doi: 10.1016/s0360-3016(02)03006-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419429 Clinical Trial.

7

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):192-8. doi: 10.1016/s0360-3016(03)00072-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694838

8

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. Valicenti RK, et al. Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):614-20. doi: 10.1016/s0360-3016(03)00640-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 14529764 Clinical Trial.

9

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Kuban DA, et al. Among authors: michalski jm. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):915-28. doi: 10.1016/s0360-3016(03)00632-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575822

10

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

Thames H, Kuban D, Levy L, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Thames H, et al. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):929-43. doi: 10.1016/s0360-3016(03)00631-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters